Next-Generation mRNA-LNP COVID-19 Vaccine(PopVax)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameNext-Generation mRNA-LNP COVID-19 Vaccine(PopVax)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPopVax Private Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPopVax Private Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A